Thu, May 23, 2024
Wed, May 22, 2024
Tue, May 21, 2024
Mon, May 20, 2024
Fri, May 17, 2024

Jessica Fye Maintained (UTHR) at Buy with Increased Target to $300 on, May 21st, 2024


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. th-increased-target-to-300-on-may-21st-2024.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Jessica Fye of JP Morgan, Maintained "United Therapeutics Corporation" (UTHR) at Buy with Increased Target from $280 to $300 on, May 21st, 2024.

Jessica has made no other calls on UTHR in the last 4 months.



There are 6 other peers that have a rating on UTHR. Out of the 6 peers that are also analyzing UTHR, 1 agrees with Jessica's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Chris Shibutani of "Goldman Sachs" Maintained at Hold with Increased Target to $240 on, Friday, May 3rd, 2024


These are the ratings of the 5 analyists that currently disagree with Jessica


  • Hartaj Singh of "Oppenheimer" Maintained at Buy with Increased Target to $400 on, Thursday, May 2nd, 2024
  • Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $300 on, Thursday, May 2nd, 2024
  • Tiago Fauth of "Wells Fargo" Maintained at Buy with Increased Target to $325 on, Thursday, March 7th, 2024
  • Liana Moussatos of "Wedbush" Reiterated at Buy and Held Target at $308 on, Thursday, February 22nd, 2024
  • Roanna Ruiz of "Leerink Partners" Initiated at Buy and Held Target at $330 on, Monday, February 5th, 2024

Publication Contributing Sources